The pre-visit intake does not include an eating-disorder screen , a mental health or depression question , an FDA black-box family history (MTC, MEN2, pancreatitis), a substance-use or alcohol screen , an allergy check , a full medication review beyond weight-loss drugs, or any diet or exercise history
As more patients use GLP-1 medications such as semaglutide and tirzepatide, clinicians are starting to ask an important question: are these drugs quietly contributing to the Read More Fragmented Care in the GLP-1 Era: What Happens When Multiple Providers Prescribe the Same Therapy
Finding Balance with GLP-1: How to Make Lasting Change Sasha Jones Sep 8, 2025 2 min read Updated: Sep 9, 2025 Over the past few years, GLP-1 medications like semaglutide and tirzepatide have become a major tool in the fight against obesity and metabolic disease
You still know the desire but it no longer screams
The agency had shared similar findings after a preliminary review in 2024, but said at that time that limited data meant a small risk could not be ruled out
